View Press Releases
-
ZeOmega Expands Reach to 38M Lives, Enhances PHM Solutions
-
PubHive Expands Local Literature Automation for Pharmacovigilance
New Internet browser extensions for Google Chrome and Microsoft Edge enables PubHive Navigator platform users to automate pharmacovigilance-related local literature monitoring work from any webpage, improving efficiency by up to 92%
Jan 31, 2022
-
Insightful Science Acquires Omiq to Add Cloud-Based Machine Learning to its Flow Cytometry Capabilities
OMIQ is a powerful flow cytometry SaaS solution adopted by leading global biopharma labs
Jan 12, 2022
-
Marpai’s AI-Powered Health Predictions Gain Traction with URAC Accredited Care Management
-
Alfa Chemistry Microfluidics: Transform Amazing Microfluidics Idea into Reality
-
Positive Technologies Uncovers Vulnerability in IDEMIA Biometric Identification Devices That Can Unlock Doors and Turnstiles
Positive Technologies announced today that its researchers have uncovered a critical vulnerability in IDEMIA biometric identification devices. When exploited, the vulnerability can allow criminals to unlock doors and turnstiles leading to protected areas within organizations, and disable access control systems.
Jan 13, 2022
-
Clinical Research Technology Leader RealTime Secures Growth Investment from LLR Partners
RealTime Software Solutions, LLC, a leader in cloud-based software solutions for the clinical research industry, today announced a significant growth investment from LLR Partners. The capital and resources from this partnership will be dedicated to helping accelerate the company’s growth, product innovation and delivery of world-class customer experiences.
Jan 13, 2022
-
Rho Promotes Mark Ubert to CFO
-
Global Digital Twin Market Research Report - Increasing Demand for Personalized Medical Therapies
The Digital Twin market growth is poised to be driven by the rising demand for personalized therapies and trend of digitization across the healthcare and medical segment.
Jan 17, 2022
-
PreOmics Announces Closing of Series B Financing to Accelerate Research, Development and Commercialization of Proteomics Tools and Consumables
-
PubHive Automates Duplicate Detection for European Medicine Agency’s MLM Data
PubHive’s AI-powered software-as-a-service platform enables drug safety and pharmacovigilance teams to automatically identify duplicate search hits from European Medicine Agency’s Medical Literature Monitoring (MLM) service and streamline ICSR reviews
Jan 18, 2022
-
Temedica Introduces Permea: First Analytics Platform Integrating Patient-Generated Health Data
-
ACM Presents PEARC22, July 10–14, in Boston
The ACM PEARC22 (Association of Computing Machinery, Practice and Experience in Advanced Research Computing) conference will be held at the Boston Park Plaza Hotel in Boston, Massachusetts, July 10–14, 2022.
Jan 18, 2022
-
Topography Health Launches with $27.5M Funding to Empower Community Physicians to Run Clinical Drug Trials
Topography Health, the world’s first full-stack clinical trials platform for community physicians, launched out of stealth this week to tackle mass scale clinical trial access: Backed by Bain Venture Capital and Andreesen Horowitz with $27.5M in funding, Topography is on a mission to expand access to clinical trials for both patients and their providers. By creating the largest network of community physicians and equipping them with the tools and staff they need to conduct medical research, Topography is making it possible for your family doctor to offer clinical drug trials as part of their practice. Research will not just be for potentially terminal illnesses, but also for moderate chronic illnesses, where the standard of care lags.
Jan 19, 2022
-
CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Formulation Projects
-
Quantum Dots & Upconverting Nanoparticles Provided by Alfa Chemistry Can Improve Medical Technology and Energy Research
-
Microarray Data Analysis Service Now Available by CD Genomics's Bioinformatics-Analysis Platform
The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. Recently, CD Genomics announced the launch of the Microarray Data Analysis service to help scientists discover the biological significance of microarray data and, at the same time, help reduce the time and cost of wet laboratory experiments and data generation.
Jan 22, 2022
-
Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service
The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information science, database construction, and management. Recently, the company announced the launch of biomarker and target discovery service for disease identification, early diagnosis and prevention, and monitoring during treatment.
Jan 22, 2022
-
BioIVT Launches GMP Grade Human AB Serum to Facilitate the Development and Manufacturing of Cell and Gene Therapies
This cell culture supplement can be used to manufacture both autologous and allogeneic cell therapies.
Jan 23, 2022
-
WuXi STA Launches its First Parenteral Formulation Manufacturing Line